Genmab — December 2017
-
-
Det er helt rigtigt set - men så længe det ikke manifesterer sig i omsætningstallene, så har vi problemer
-
-
ved cut-off den 12. juni var 5% af VMP gruppen stadig i behandling - 71% af D-VMP gruppen var stadig i behandling
-
Det må være her at maintenance er bygget ind i studiet og skaber dybere og længere responser
-
Nydelig præsentation - der kan vist ikke være ret meget tvivl om at Darzalex bliver SOC
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind